Scinovex
articleTop 1% cited

Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery

Journal of Controlled Release · 2014 · Vol. 192 · pp. 262–270
Luisa PascucciValentina CoccèArianna BonomiDiletta AmiPiero CeccarelliEmilio CiusaniLucia ViganòAlberta LocatelliFrancesca SistoSilvia Maria DogliaEugenio ParatiMaria Ester BernardoMaurizio MuracaGiulio AlessandriGianpietro BondiolottiAugusto Pessina
Extracellular vesicles in diseaseMicroRNA in disease regulationMesenchymal stem cell researchMicrovesiclesMesenchymal stem cellPaclitaxelChemistryStromal cellIn vitroDrug deliveryExosomeCell biologyCell culture

MeSH terms

AnimalsAntineoplastic AgentsCell LineHumansNeoplasmsDrug Delivery SystemsPaclitaxelCell Line, TumorMiceExosomesMesenchymal Stem Cells

Funding

  • Associazione Italiana per la Ricerca sul Cancro
Citations
880
FWCI
13.10
field-weighted impact
References
65
Percentile
99%
vs. same field & year
Citations per year
Cited by
Advances in therapeutic applications of extracellular vesicles
Science Translational Medicine · 2019 · 983 citations
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Journal of Controlled Release · 2015 · 1,095 citations
Extracellular vesicles for drug delivery
Advanced Drug Delivery Reviews · 2016 · 1,204 citations
Extracellular vesicles as drug delivery systems: Why and how?
Advanced Drug Delivery Reviews · 2020 · 1,147 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.